Clinical and Laboratory Improvement in Hyperadrenergic Postural Orthostatic Tachycardia Syndrome (POTS) after COVID-19 Infection

A 32-year-old woman with a history of symptomatic supraventricular tachycardia, inappropriate sinus tachycardia, and hyperadrenergic POTS was treated with ivabradine and metoprolol. She then presented with bradycardia and Mobitz II second-degree AV block on event monitoring six weeks after COVID-19...

Descripción completa

Detalles Bibliográficos
Autores principales: Ocher, Rebecca A., Padilla, Erika, Hsu, Jonathan C., Taub, Pam R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405341/
https://www.ncbi.nlm.nih.gov/pubmed/34471549
http://dx.doi.org/10.1155/2021/7809231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405341/
https://www.ncbi.nlm.nih.gov/pubmed/34471549
http://dx.doi.org/10.1155/2021/7809231

Ejemplares similares